Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer

Laura M Spring^#¹, Hyo Han^#², Minetta C Liu³, Erika Hamilton⁴, Hanna Irie⁵, Cesar A Santa-Maria⁶, James Reeves⁷, Peng Pan^{8

9}, Ming Shan^{8

10}, Yongqiang Tang⁸, Julie R Graham^{8

11}, Sebastien Hazard^{8

12}, Leif W Ellisen^{1

13}, Steven J Isakoff¹⁴

Affiliations

¹ Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
² Moffitt Cancer Center-McKinley Outpatient Clinic, Tampa, FL, USA.
³ Mayo Clinic, Rochester, MN, USA.
⁴ Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
⁵ Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁶ Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
⁷ Florida Cancer Specialists-South/Sarah Cannon Research Institute, Fort Myers, FL, USA.
⁸ GSK, Waltham, MA, USA.
⁹ EQRx, Cambridge, MA, USA.
¹⁰ Translational Discovery & Development, Boston Pharmaceuticals, Boston, MA, USA.
¹¹ Alkermes Incorporated, Waltham, MA, USA.
¹² Bicycle Therapeutics, Boston, MA, USA.
¹³ Ludwig Center at Harvard, Boston, MA, USA.
¹⁴ Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. SISAKOFF@mgh.harvard.edu.

^# Contributed equally.

Published Erratum

Laura M Spring et al. Nat Cancer. 2022 Sep.

. 2022 Sep;3(9):1138.

doi: 10.1038/s43018-022-00430-w.

¹ Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
² Moffitt Cancer Center-McKinley Outpatient Clinic, Tampa, FL, USA.
³ Mayo Clinic, Rochester, MN, USA.
⁴ Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
⁵ Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁶ Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
⁷ Florida Cancer Specialists-South/Sarah Cannon Research Institute, Fort Myers, FL, USA.
⁸ GSK, Waltham, MA, USA.
⁹ EQRx, Cambridge, MA, USA.
¹⁰ Translational Discovery & Development, Boston Pharmaceuticals, Boston, MA, USA.
¹¹ Alkermes Incorporated, Waltham, MA, USA.
¹² Bicycle Therapeutics, Boston, MA, USA.
¹³ Ludwig Center at Harvard, Boston, MA, USA.
¹⁴ Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. SISAKOFF@mgh.harvard.edu.

^# Contributed equally.

No abstract available

Erratum for

Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.
Spring LM, Han H, Liu MC, Hamilton E, Irie H, Santa-Maria CA, Reeves J, Pan P, Shan M, Tang Y, Graham JR, Hazard S, Ellisen LW, Isakoff SJ. Spring LM, et al. Nat Cancer. 2022 Aug;3(8):927-931. doi: 10.1038/s43018-022-00400-2. Epub 2022 Jul 4. Nat Cancer. 2022. PMID: 35788722 Free PMC article. Clinical Trial.